Oxidative stress of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 2, 2007, Pages

  Coirault, Catherine ^a,b   Guellich, Aziz ^a,b   Barbry, Thomas ^c,d   Samuel, Jane Lise ^a,b   Riou, Bruno ^d,e   Lecarpentier, Yves ^a,f,g  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f BICÊTRE HOSPITAL   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Congestive heart failure; Contractile proteins; Diaphragm

Indexed keywords

MOLECULAR MOTOR; MYOSIN;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; AORTA STENOSIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAPHRAGM; IMMUNOBLOTTING; IN VITRO STUDY; LIPID PEROXIDATION; MALE; MUSCLE WEAKNESS; MYOPATHY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOLEUS MUSCLE; VELOCITY;

ANIMALS; DIAPHRAGM; DISEASE MODELS, ANIMAL; HEART FAILURE, CONGESTIVE; LIPID PEROXIDATION; MALE; MOLECULAR MOTOR PROTEINS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SKELETAL MUSCLE MYOSINS;

EID: 33846968494     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00438.2006     Document Type: Article

References (52)

1. Adams V, Jiang H, Yu J, Mobius-Winkler S, Fiehn E, Linke A, Weigl C, Schuler G, Hambrecht R. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol 33: 959-965, 1999.
2. 2+ release channels in rat cardiac hypertrophy induced by aortic stenosis. Circulation 98: 2477-2486, 1998.
3. Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SNA, Gea J. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 1116-1124, 2005.
4. Bottinelli R, Schiaffino S, Reggiani C. Force-velocity relations and myosin heavy chain isoform compositions of skinned fibres from rat skeletal muscle. J Physiol 437: 655-672, 1991.
5. Brutsaert DL, Claes VA, Goethals MA. Effect of calcium on force-velocity-length relations of heart muscle of the cat. Circ Res 32: 385-392, 1973.
6. Canton M, Neverova I, Menabo R, Van Eyk J, Di Lisa F. Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am J Physiol Heart Circ Physiol 286: H870-H877, 2004.
7. Coirault C, Lambert F, Marchand-Adam S, Attal P, Chemla D, Lecarpentier Y. Myosin molecular motor dysfunction in dystrophic mouse diaphragm. Am J Physiol Cell Physiol 277: C1170-C1176, 1999.
8. Coirault C, Lambert F, Pourny JC, Lecarpentier Y. Velocity of actomyosin sliding in vitro is reduced in dystrophic mouse diaphragm. Am J Respir Crit Care Med 165: 250-253, 2002.
9. Couillard A, Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, LeBlanc P, Préfaut C. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstrucyive pulmonary disease. Am J Respir Crit Care Med 167: 1664-1669, 2003.
10. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 9: 169-176, 2003.
11. de Simone G, Wallerson DC, Volpe M, Devereux RB. Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation. Am J Hypertens 3: 688-696, 1990.
12. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R. Subcellular creatine kinase alterations. Implications in heart failure. Circ Res 85: 68-76, 1999.
13. Dirks A, Leeuwenburgh C. Apoptosis in skeletal muscle with aging. Am J Physiol Regul Integr Comp Physiol 282: R519-R527, 2002.
14. Duscha BD, Annex BH, Keteyian SJ, Gree HJ, Sullivan MJ, Samsa GP, Brawner CA, Schachat FH, Kraus WE. Differences in skeletal muscle between men and women with chronic heart failure. J Appl Physiol 90: 280-286, 2001.
15. Filippatos GS, Kanatselos C, Manolatos DD, Vougas B, Sideris A, Kardara D, Anker SD, Kardaras F, Uhal B. Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia. Int J Cardiol 90: 107-113, 2003.
16. Hambrecht R, Adams V, Gielen S, Linke A, Mobius-Winkler S, Yu J, Niebauer J, Jiang H, Fiehn E, Schuler G. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol 33: 174-179, 1999.
17. Homsher E, Nili M, Chen Y, Tobacman LS. Regulatory proteins alter nucleotide binding to act-myosin of sliding filaments in motility assays. Biophys J 85: 1046-1052, 2003.
18. Hook P, Larsson L. Actomyosin interactions in a novel single muscle fiber in vitro motility assay. J Muscle Res Cell Motil 21: 357-365, 2000.
19. Huxley AF. Muscle structure and theories of contraction. Prog Biophys Biophys Chem 7: 255-318, 1957.
20. Kaasik A, Minajeva A, De Sousa E, Ventura-Clapier R, Veksler V. Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase. FEBS Lett 444: 75-77, 1999.
21. Keller DI, Coirault C, Rau T, Cheav T, Weyand M, Amann K, Lecarpentier Y, Richard P, Eschenhagen T, Carrier L. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties. J Mol Cell Cardiol 36: 355-362, 2004.
22. 2+-ATPase in low-frequency stimulated rabbit muscle. FEBS Lett 422: 381-384, 1998.
23. Kron SJ, Spudich JA. Fluorescent actin filaments move on myosin fixed to a glass surface. Proc Natl Acad Sci USA 83: 6272-6276, 1986.
24. Lecarpentier Y, Chemla Blanc FX, Pourny JC, Riou B, Coirault C. Mechanics, energetics and crossbridge kinetics of rabbit diaphragm during congestive heart failure. FASEB J 12: 981-989, 1998.
25. Lecarpentier Y, Coirault C, Lerebours G, Desche P, Scalbert E, Lambert F, Chemla D. Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain. Am J Respir Crit Care Med 155: 630-636, 1997.
26. Libera LD, Zennaro R, Sandri M, Ambrosio GB, Vescovo G. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am J Physiol Cell Physiol 277: C982-C986, 1999.
27. Libera LD, Vescovo G. Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: a chimaeric view of inflammation? Curr Opin Clin Nutr Metab Care 7: 435-444, 2004.
28. Lindsay DC, Lovegrove CA, Dunn MJ, Bennett JG, Pepper JR, Yacoub MH, Poole-Wilson PA. Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J 17: 1239-1250, 1996.
29. Lowe DA, Surek JT, Thomas DD, Thompson LV. Electron paramagnetic resonance reveals age-related myosin structural changes in rat skeletal muscle fibers. Am J Physiol Cell Physiol 280: C540-C547, 2001.
30. Lowey S, Waller GS, Trybus KM. Function of skeletal muscle myosin heavy and light chain isoforms by an in vitro motility assay. J Biol Chem 268: 20414-20418, 1993.
31. Massie BM, Simonini A, Sahgal P, Wells L, Dudley GA. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure. J Am Coll Cardiol 27: 140-145, 1996.
32. McParland C, Resch EF, Krishnan B, Wang Y, Cujec B, Gallagher CG. Inspiratory muscle weakness in chronic heart failure: role of nutrition and electrolyte status and systemic myopathy. Am J Respir Crit Care Med 151: 1101-1107, 1995.
33. Mihm MJ, Yu F, Reiser PJ, Bauer JA. Effects of peroxynitrite on isolated cardiac trabeculae: selective impact on myofibrillar energetic controllers. Biochimie 85: 587-596, 2003.
34. Moretti A, Weig HJ, Ott T, Seyfarth M, Holthoff HP, Grewe A, Bott-Flugel L, Schomig A, Ungerer M, Laugwitz KL. Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci USA 99: 11860-11865, 2002.
35. Mortola JP, Naso L. Electrophoretic analysis of contractile proteins of the diaphragm in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 269: L371-L376, 1995.
36. Pardee JD, Spudich JA. Purification of muscle actin. Methods Enzymol 85: 164-181, 1982.
37. Persinger R, Janssen-Heininger Y, Wing SS, Matthews DE, LeWinter MM, Toth MJ. Effect of heart failure on the regulation of skeletal muscle protein synthesis, breakdown, and apoptosis. Am J Physiol Endocrinol Metab 284: E1001-E1008, 2003.
38. Poole-Wilson PA, Ferrari R. Role of skeletal muscle in the syndrome of chronic heart failure. J Mol Cell Cardiol 28: 2275-2285, 1996.
39. Ramamurthy B, Hook P, Jones AD, Larsson L. Changes in myosin structure and function in response to glycation. FASEB J 15: 2415-2422, 2001.
40. Reggiani C, Bottinelli R, Stienen GJ. Sarcomeric myosin isoforms: fine tuning of a molecular motor. News Physiol Sci 15: 26-33, 2000.
41. Schaufelberger M, Eriksson BO, Lonn L, Rundqvist B, Sunnerhagen KS, Swedberg K. Skeletal muscle characteristics, muscle strength and thigh muscle area in patients before and after cardiac transplantation. Eur J Heart Fail 3: 59-67, 2001.
42. Sellers JR, Cuda G, Wang F, Homsher E. Myosin-specific adaptations of the motility assay. Methods Cell Biol 39: 23-49, 1993.
43. Sieck GC, Zhan WZ, Prakash YS, Daood MJ, Watchko JF. SDH and actomyosin ATPase activities of different fiber types in rat diaphragm muscle. J Appl Physiol 79: 1629-1639, 1995.
44. Siemankowski RF, Wiseman MO, White HD. ADP dissociation from actomyosin subfragment 1 is sufficiently slow to limit the unloaded shortening velocity in vertebrate muscle. Proc Natl Acad Sci USA 82: 658-662, 1985.
45. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81: 518-527, 1990.
46. Tardiff JC, Factor SM, Tompkins BD, Hewett TE, Palmer BM, Moore RL, Schwartz S, Robbins J, Leinwand LA. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial cardiomyopathy. J Clin Invest 101: 2800-2811, 1998.
47. Tikunov BA, Mancini D, Levine S. Changes in myofibrillar protein composition of human diaphragm elicited by congestive heart failure. J Mol Cell Cardiol 28: 2537-2541, 1996.
48. Tsutsui H. Oxidative stress in heart failure: the role of mitochondria. Intern Med 40: 1177-1182, 2001.
49. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274: 2234-2242, 1999.
50. Ventura-Clapier R, De Sousa E, Veksler V. Metabolic myopathy in heart failure. News Physiol Sci 17: 191-196, 2002.
51. Vivien B, Lecarpentier Y, Riou B, Coirault C. Halothane and isoflurane do not directly interact with cardiac cross-bridge function. Anesthesiology 102: 363-370, 2005.
52. Ward CW, Reiken S, Marks AR, Marty I, Vassort G, Lacampagne A. Defects in ryanodine receptor calcium release in skeletal muscle from post-myocardial infarct rats. FASEB J 17: 1517-1519, 2003.